Frontier Wellness Management Inc. (“Frontier”) is entering the emerging European cannabinoid market via strategic acquisitions.
Frontier will initially focus on specific geographic regions in the EU that allow for the legal sale of cannabinoids.
An opportunity exists to enter the burgeoning European cannabinoid market, and Frontier Wellness Management is leading the expedition. Identifying Spain to be the quickest and most lucrative path to growth, Frontier is acquiring valuable assets to lay the groundwork for national, then continental expansion.
Spain boasts amongst the highest rates of cannabinoid consumption of any country in Europe, with extensive medical use. Frontier’s plan is to focus on Medcan, the only retail operator of cannabinoid clinics in Spain.
Spain’s federal government has allowed its autonomous communities to create their own recreational and medical cannabinoid laws to meet the needs of their citizens.
In Spain, the consumption and cultivation of cannabinoids for your own personal use, even when it is for shared consumption is constitutionally protected. Smoking marijuana in public places can result in a fine.
Catalonia has many similarities to the California cannabinoid market in 2010
Chairman & CEO
John MacPhail was most recently CEO of I-5 Holdings Ltd. a Canadian company focused on the US retail cannabinoid market. I-5 was acquired by Captor Capital Corp. after raising CAD $83 million bringing the company public. Mr. MacPhail is also the Chairman of Wealthcraft Capital, a US company focused on pain management treatment through cannabinoids and Green Stripe Naturals a Jamaican cannabinoid company. Before entering the cannabinoid market Mr. MacPhail boasts a near 30 year career as an investment banker most recently being the CEO of Union Securities based out of Vancouver BC.
Mr. Duda is a Chartered Professional Accountant with over 30 years of senior industry experience with public and private companies. He holds a Bachelor of Business Administration degree and numerous Canadian Securities Institute accreditations. Mr. Duda is managing director of Delmac Pacific Management Inc., a private organization that provides consulting and advisory services to the financial services, mining, technology and medical industries. Mr. Duda recently served as Chief Financial Officer and Corporate Secretary of Northern Vertex Mining Corp. and Element Lifestyle Retirement Inc. He has also held senior positions with Haywood Securities Inc., Blackmont Capital Inc. (formerly First Associates Investments Inc. and Yorkton Securities Inc.), Union Securities Ltd. and Omni Vita Custom Wealth Management Inc.
Carlos Bello is a global marketing, sales and customer operations executive with nearly 30 years results-oriented business management experience. A 20-year HP veteran, he recently managed the $200M SMB Inkjet Hardware Category in EMEA. He was responsible for growing and maximizing revenue, market share and profit. Mr. Bello played a central role in establishing a new category, positioning it in the marketplace, and driving above market growth leveraging key channel partners. He has also held positions in marketing, customer experience, training, and finance and was also the Commercial Director of an award- winning London Based online education services provider. Carlos holds an undergraduate degree in Communications from Villanova University and an MBA from the University of Maryland.
VP Project Development
Jack MacPhail was most recently the Project Development Manager of I-5 Holdings Ltd. overseeing the Washington State division. Prior to being in the cannabinoid space he worked as a research analyst for CIBT Education Group Inc. an education company in Vancouver BC. Mr. MacPhail was personally responsible for the modeling of over $1 billion in real estate assets and oversaw the renovation of a class B building in downtown Vancouver along with the development of a class A building in Burnaby BC. Mr. MacPhail received his B.A. in Economics, and a B.S. in business administration with a minor in finance from Chapman University.
Mr. Wilson has been involved in investment management, investment banking, M&A, corporate governance and management for over 35 years. He co-founded the private debt fund, Temperance Capital where he continues to act as Managing Director. Prior to forming Temperance, Mr. Wilson served as an executive and director of a number of private investment funds and public companies including as executive vice president and director of Asia BioChem Group where he was responsible for all corporate governance, financial and regulatory reporting. He was also a director of Liuyang Fireworks (chairman of audit committee and chairman of the special committee for the company’s privatization) and Gourmet Ocean Products (chairman of the special committee for the company’s privatization); and a Managing Director of Mackie Research Capital Corporation. Mr. Wilson holds a Bachelor of Commerce degree from Carleton University and currently serves as a director and senior executive of Wealthcraft Capital Corp.
John MacPhail was most recently CEO of I-5 Holdings Ltd. a Canadian company focused on the US retail cannabinoid market. I-5 was acquired by Captor Capital Corp. after raising $CAD 83 million bringing the company public. Mr. MacPhail is also the Chairman of Wealthcraft Capital, a US company focused on pain management treatment through cannabinoids. and Green Stripe Naturals. Before entering the cannabinoid market Mr. MacPhail boasts a near 30 year career as an investment banker most recently being the CEO of Union Securities based out of Vancouver BC.
Mr. Isaacs is the founder and CEO of JEZANO. Mr. Isaacs is Jamaican born Canadian citizen who has had a long standing business interest in the world wide legal commercialization of natural and herbal, ailment specific treatment. A graduate of the prestigious Western University, Mr. Isaacs has been very successful in creating value for shareholders in nascent industries. Mr. Isaacs has served as senior executive and director of over 30 publicly listed companies in Canada during his 28 year career on Bay Street. He has been awarded the Harry Jerome Award for Business and the Herbert Carnegie Future Aces Award for Entrepreneurship in recognition of his business success. He has been featured in print and televised media worldwide and has appeared as speaker / presenter at conferences in countries such as China, Dubai, Germany, South Africa, Canada and the United States.
Joan De Haro
Joan De Haro is the founder and CEO of Medcan, an MBA and lecturer in International Economy at ESADE Business School.
Mr. Haro is also the founder of Kalapa Clinic, the first medical cannabis clinic in Europe, which exited in 2015 to bring Medcan to retail. He was an international distribution network executive with a 15 year career promoting Spanish made products in the Russian market for such brands as Roca, Pamesa and Aparici before entering the cannabinoid market.